A management theme centered on a business model that provides comprehensive support for drug discovery research by leveraging biological resources and genetic information, genomics, advanced medicine, CROs and pathological diagnostics, and on contributing to health and fulfilling lives. It also includes a policy of adapting the business model and business structure to the business environment.